← Back to Clinical Trials
Recruiting NCT05868421

NCT05868421 Veteran Social Support for Enhancing Use of Smoking Cessation Treatment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05868421
Status Recruiting
Phase —
Sponsor VA Office of Research and Development
Condition Smoking Cessation
Study Type INTERVENTIONAL
Enrollment 2,376 participants
Start Date 2024-02-01
Primary Completion 2027-02-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Support Person Coaching CallSP written materialsWritten Smoking Cessation Materials

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 2,376 participants in total. It began in 2024-02-01 with a primary completion date of 2027-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is recruiting Veterans who currently smoke cigarettes and support persons who are nominated by the Veterans. The purpose of this study is to assist Veterans with smoking cessation by asking Veterans to choose a support person who will assist them with the quitting process, or who may assist them with the quitting process once the Veteran is ready to quit smoking sometime in the future. Study staff will assess how much or how little social support during the Veteran's quitting process is helpful to the Veteran. This information will help us come up with new ways to help Veterans quit smoking that are better tailored to their needs.

Eligibility Criteria

Inclusion Criteria: Veteran Inclusion Criteria * Smoked 1 cigarettes over the past 30 days, even a puff * If using other tobacco or nicotine products, cigarettes are the main product used * Able to identify one adult family member or friend (SP) with whom they have contact (of any form) at least 3 times per week who will enroll Veteran Support Person Inclusion Criteria * Willing to support the Veteran smoker * Have to have access to any type of phone (or tablet for video call) for delivery of the SP intervention Exclusion Criteria: Veteran Exclusion Criteria * Have used cessation medications or a stop smoking program within the past 3 months * Have no valid phone contact information

Contact & Investigator

Central Contact

Alicia B Woodward-Abel

✉ alicia.woodward-abel@va.gov

📞 (612) 467-1229

Principal Investigator

Steven S. Fu, MD MSCE

PRINCIPAL INVESTIGATOR

Minneapolis VA Health Care System, Minneapolis, MN

Frequently Asked Questions

Who can join the NCT05868421 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05868421 currently recruiting?

Yes, NCT05868421 is actively recruiting participants. Contact the research team at alicia.woodward-abel@va.gov for enrollment information.

Where is the NCT05868421 trial being conducted?

This trial is being conducted at Minneapolis, United States.

Who is sponsoring the NCT05868421 clinical trial?

NCT05868421 is sponsored by VA Office of Research and Development. The principal investigator is Steven S. Fu, MD MSCE at Minneapolis VA Health Care System, Minneapolis, MN. The trial plans to enroll 2,376 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology